Effect of manganese on guinea pig ventricle: Initial depression and late augmentation of contractile force

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 3, 2002, Pages 323-326

  Tanaka, Hikaru ^a   Ishii, Tadashi ^a   Fujisaki, Ryoichi ^a   Miyamoto, Yusuke ^a   Tanaka, Yoshino ^a   Aikawa, Tokiko ^a   Hirayama, Wataru ^a   Kawanishi, Toru ^b   Shigenobu, Koki ^a  

^a TOHO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Guinea pig; Inotropism; Manganese; Myocardium

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION; MANGANESE; MANGANESE CHLORIDE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NICARDIPINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; FEMALE; FLUORESCENCE; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE CONTRACTION; INOTROPISM; ISOLATION PROCEDURE; MALE; NONHUMAN; SARCOPLASMIC RETICULUM; ANIMAL; GUINEA PIG; HEART CONTRACTION; HEART VENTRICLE; IN VITRO STUDY; PHYSIOLOGY;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DILTIAZEM; FEMALE; GUINEA PIGS; HEART VENTRICLES; MALE; MANGANESE; MYOCARDIAL CONTRACTION; NICARDIPINE;

EID: 0036516418     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.323     Document Type: Article

References (22)

1. Kavaler F., Brommundt G., Am. J. Physiol., 253, C52-C59 (1987).
2. Vierling W., Reiter M., Arch. Pharmacol., 306, 249-253 (1979).
3. Tsunobuchi H., Gomi Y., J. Pharmacobio-Dyn., 13, 285-291 (1990).
4. Kato Y., Masumiya H., Agata N., Tanaka H., Shigenobu K., J. Mol. Cell. Cardiol., 28, 1515-1522 (1996).
5. Nishimaru K., Tanaka Y, Tanaka H., Shigenobu K., Am. J. Physiol. 280, H132-H141 (2001).
6. Hryshko L. V., Stiffel V., Bers D. M., Am. J. Physiol., 257, H1369-H1377 (1989).
7. Kurihara S., Sakai T., J. Physiol. (London), 361, 361-378 (1985).
8. Ochi R., J. Physiol. (London), 263, 139-156 (1976).
9. Brommundt G., Kavaler F., Am. J. Physiol., 253, C45-C51 (1987).
10. Frame M. D., Milanick M. A., Am. J. Physiol., 261, C467-C475 (1991).
11. Oota I., Takauji M., Nagai T., Jpn. J. Physiol., 22, 379-392 (1972).
12. Gavin C. E., Gunter K. K., Gunter T. E., Neurotoxicology, 20, 455-453 (1999).
13. Tanaka H., Kawanishi T., Kato Y., Nakamura R., Shigenobu K., Jpn. J. Pharmacol., 70, 235-242 (1996).
14. Feher J. J., Rebeyka I. M., Am. J. Physiol., 267, H962-H969 (1994).
15. Bansal S. K., Murthy R. C., Chandra S. V., Ecotoxicol. Environ. Saf., 9, 373-377 (1985).
16. Agata N., Tanaka H., Shigenobu K., Eur. J. Pharmacol., 222, 223-226 (1992).
17. Takeya K., Reiter M., Naunyn-Schmiedeberg's Arch. Pharmacol., 275, 213-226 (1972).
18. Willerson J. T., Wheelan S., Adcock R. C., Templeton G. H., Wildenthal K., Am. J. Physiol., 235: H276-H280 (1978).
19. Sutko J. L., Willerson J. T., Circ. Res., 46, 332-343 (1980).
20. Tanaka H., Shigenobu K., J. Mol. Cell. Cardiol., 21, 1305-1313 (1989).
21. Agata N., Tanaka H., Shigenobu K., Eur. J. Pharmacol., 260, 47-55 (1994).
22. Morad M., Goldman Y. E., Trentham D. R., Nature (London), 304, 635-638 (1983).